Results 121 to 130 of about 5,708 (209)

On Weak Limits and Unimodular Measures

open access: yes, 2014
In this thesis, the main objects of study are probability measures on the isomorphism classes of countable, connected rooted graphs. An important class of such measures is formed by unimodular measures, which satisfy a certain equation, sometimes ...
Artemenko, Igor
core  

Virology [PDF]

open access: yes
Avian influenza viruses, notably H5 subtype viruses, pose a continuous threat to public health due to their pandemic potential. In recent years, influenza virus H5 subtype split vaccines with novel oil-in-water emulsion based adjuvants (e.g.

core  

Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies

open access: yesNature Communications
Highly pathogenic H5N1 avian influenza viruses of clade 2.3.4.4b cause sporadic human infections and currently raise concerns about a new influenza pandemic.
Mariana Alcocer Bonifaz   +4 more
doaj   +1 more source

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2

open access: yesbioRxiv, 2023
Yupeng Feng   +23 more
semanticscholar   +1 more source

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

open access: yesLancet. Infectious Diseases (Print), 2022
S. Sridhar   +45 more
semanticscholar   +1 more source

Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.

open access: yesVaccine, 2023
L. Jackson   +17 more
semanticscholar   +1 more source

Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.

open access: yesLancet. Infectious Diseases (Print), 2022
N. Folschweiller   +19 more
semanticscholar   +1 more source

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines

open access: yesmedRxiv, 2022
G. Bruyn   +37 more
semanticscholar   +1 more source

Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network. [PDF]

open access: yesClin Infect Dis
Atmar RL   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy